Literature DB >> 16412713

Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration.

Andrea I Alford1, Kurt D Hankenson.   

Abstract

Matricellular proteins are components of the extracellular matrix which are highly expressed in the developing and mature skeleton. Members of this protein class serve as biological mediators of cell function by interacting directly with cells or by modulating the activity of growth factors, proteases, and other extracellular matrix proteins. Although skeletons of matricellular protein-null mice are grossly normal, they each display unique deficiencies that are often magnified under pathological conditions. In addition, bone cells from wild-type and matricellular protein-null mice behave differently in various in vitro models of bone matrix synthesis and turnover. In this review, osteopontin, bone sialoprotein, tenascin C, SPARC, and thrombospondins 1 and 2 will each be discussed in the context of bone cell biology. Because the biological effects of matricellular proteins are largely context dependent, in vivo and in vitro results must be considered together in order to fully appreciate the specific contributions that matricellular proteins make to bone physiology and pathophysiology. In particular, it is clear that although matricellular proteins are not required for bone development and function, the proteins act to modulate post-natal bone structure in response to aging, ovariectomy, mechanical loading, and bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412713     DOI: 10.1016/j.bone.2005.11.017

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  76 in total

Review 1.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

2.  Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.

Authors:  Melita M Dvorak-Ewell; Tsui-Hua Chen; Nathan Liang; Caitlin Garvey; Betty Liu; Chialing Tu; Wenhan Chang; Daniel D Bikle; Dolores M Shoback
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

3.  The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Authors:  Mariya T Sweetwyne; Manuel A Pallero; Ailing Lu; Lauren Van Duyn Graham; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 4.  The multiple facets of periostin in bone metabolism.

Authors:  B Merle; P Garnero
Journal:  Osteoporos Int       Date:  2012-02-07       Impact factor: 4.507

Review 5.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

6.  Regulation of tenascin expression in bone.

Authors:  Jessica M Morgan; Alice Wong; Clare E Yellowley; Damian C Genetos
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 7.  Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations.

Authors:  John F Bateman; Raymond P Boot-Handford; Shireen R Lamandé
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

8.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

Review 9.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

10.  Post-transcriptional regulation in osteoblasts using localized delivery of miR-29a inhibitor from nanofibers to enhance extracellular matrix deposition.

Authors:  Eric N James; Anne M Delany; Lakshmi S Nair
Journal:  Acta Biomater       Date:  2014-05-09       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.